Direct‐acting antivirals for chronic hepatitis C

BACKGROUND: Millions of people worldwide suffer from hepatitis C, which can lead to severe liver disease, liver cancer, and death. Direct‐acting antivirals (DAAs) are relatively new and expensive interventions for chronic hepatitis C, and preliminary results suggest that DAAs may eradicate hepatitis...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cochrane Database Syst Rev
Autori principali: Jakobsen, Janus C, Nielsen, Emil Eik, Feinberg, Joshua, Katakam, Kiran Kumar, Fobian, Kristina, Hauser, Goran, Poropat, Goran, Djurisic, Snezana, Weiss, Karl Heinz, Bjelakovic, Milica, Bjelakovic, Goran, Klingenberg, Sarah Louise, Liu, Jian Ping, Nikolova, Dimitrinka, Koretz, Ronald L, Gluud, Christian
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Ltd 2017
Soggetti:
Medicine General & Introductory Medical Sciences
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6484383/
https://ncbi.nlm.nih.gov/pubmed/28585310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012143.pub2
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi